Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans

Metabolism: Clinical and Experimental

Volumn 49, Issue 12, 2000, Pages 1579-1587

  Sreenan, Seamus K ^a   Mittal, Anshu A ^a   Dralyuk, Flora ^a   Pugh, William L ^a   Polonsky, Kenneth S ^a   Roe, Michael W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CHOLERA TOXIN; GLUCAGON LIKE PEPTIDE 1; NITRENDIPINE;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT STRAIN;

EID: 0034532190     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.18555     Document Type: Article

References (62)

1. Glucagon-like peptide 1 7-36: A physiological incretin in man
2. Glucagon-like peptide-1, a new hormone of the entero-insular axis
3. Insulinotropic hormone glucagon-like peptide-1 (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells
4. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107)amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach
5. Glucagon-like peptide-1 (7-36)-NH2: A physiological inhibitor of gastric acid secretion in man
6. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells
7. A role for glucagon-like peptide-1 in the central regulation of feeding
8. Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells
9. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells
10. Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short- or long-term administration
11. Insulinotropic action of glucagon-like peptide-1-(7-37) in diabetic and non-diabetic subjects
12. Preserved incretin activity of glucagon-like peptide 1[7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
13. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas
14. Pancreatic beta cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-37)
15. Altered glucose dependence of glucagon-like peptide-1 (7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas
16. Influence of glucagon-like peptide-1 on β-cell responsiveness
17. Glucagon-like peptide 1 (7-37) actions on endocrine pancreas
18. Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor
19. Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon-like peptide 1
20. Cloning and functional expression of the human islet GLP-1 receptor: Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor
21. Glucagon-like peptide I increases cytoplasmic calcium in insulin secreting βTC3-cells by enhancement of intracellular calcium mobilization
22. Signal transduction of the GLP-1-receptor cloned from a human insulinoma
23. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C
24. Signal transduction by the cloned glucagon-like peptide-1 receptor: Comparison with signaling by the endogenous receptors of β-cell lines
25. 2+-concentration in rat islet cells
26. 2+-signalling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1
27. 2+ channel activity
28. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat
29. Changes in pancreatic islet glucokinase and hexokinase with increasing age, obesity and the onset of diabetes
30. Voltage-dependent intracellular calcium release from mouse islets stimulated by glucose
31. 2+ channel activity
32. Human studies with glucagon-like-peptide-1: Potential of the gut hormone for clinical use
33. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM
34. Desensitization of glucagon-like peptide 1 receptors in insulin-secreting βTC3 cells: Role of PKA-independent mechanisms
35. The role of the free cytosolic calcium level in β-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I (7-37)
36. Incretin hormones regulate glucose-dependent insulin secretion in RIN1046-38 cells: Mechanisms of action
37. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: Studies with the antagonist exendin 9-39
38. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1
39. Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release
40. + -dependent manner
41. Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1 (7-36 amide) in individual ob/ob mouse β-cells
42. Signal transmission after GLP-1 (7-36) amide binding in RINm5F cells
43. GLP-1 (7-36) amide stimulates insulin secretion in rat islets: Studies on the mode of action
44. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A
45. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion
46. Glucagon-like peptide-1 (7-36) amide and cytoplasmic calcium in insulin producing cells
47. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
48. Molecular mechanism underlying glucagon-like peptide 1 induced calcium mobilization from internal stores in insulin-secreting βTC3 cells
49. ADP ribosylation by cholera toxin identifies three G-proteins that are activated by the galanin receptor. Studies with RINm5F cell membranes
50. Stimulation by cholera toxin of ADP-ribosylation of membrane proteins, adenylate cyclase and insulin release in pancreatic islets
51. S has greater functional activity than the 52-kDa α-subunit
52. Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase
53. Functional effects of transgenic expression of cholera toxin in pancreatic beta-cells
54. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway
55. Growth and protein phosphorylation in the Nb2 lymphoma: Effect of prolactin, cAMP, and agents that activate adenylate cyclase
56. Multiple pathways for signal transduction in the regulation of arachidonic acid metabolism in rat peritoneal macrophages
57. Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer
58. Inhibition of noradrenaline release from PC12 cells by the long-term treatment with cholera toxin
59. Evidence for direct coupling of pancreatic GLP-1 receptor to different G-protein alpha subunits
60. Cholera toxin induces cyclic AMP-independent down-regulation of Gs alpha and sensitization of alpha 2-autoreceptors in chick sympathetic neurons
61. Characteristics of desensitization of insulin secretion in fully in vitro systems
62. Effects of short-term culturing on islet phosphoinositide and insulin secretory responses to glucose and carbachol